Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors.

about

Cancer Immunotherapy Targeted Glypican-3 or Neoantigens.Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy Precision medicine in pediatric oncology

P2860

Q47760070-A274AA03-97DD-428D-802A-B6672494D48A Q56892924-B13C5102-2D89-4670-A27B-62D6EC083507 Q57384544-CA1EB1CA-8C6E-4440-8944-EAADD9D732F5

P2860

Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors.

Item

http://www.wikidata.org/entity/Q47118215

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Phase I study of glypican-3-de ...... actory pediatric solid tumors.

@en

Phase I study of glypican-3-de ...... actory pediatric solid tumors.

@nl

type

Item

label

Phase I study of glypican-3-de ...... actory pediatric solid tumors.

@en

Phase I study of glypican-3-de ...... actory pediatric solid tumors.

@nl

prefLabel

Phase I study of glypican-3-de ...... actory pediatric solid tumors.

@en

Phase I study of glypican-3-de ...... actory pediatric solid tumors.

@nl

P1476

Phase I study of glypican-3-de ...... actory pediatric solid tumors.

@en

P2093

Ako Hosono

http://www.w3.org/2001/XMLSchema#string

Atsushi Manabe

http://www.w3.org/2001/XMLSchema#string

Chika Nitani

http://www.w3.org/2001/XMLSchema#string

Hide Kaneda

http://www.w3.org/2001/XMLSchema#string

Hiroki Yoshihara

http://www.w3.org/2001/XMLSchema#string

Junichi Hara

http://www.w3.org/2001/XMLSchema#string

Kayoko Shoda

http://www.w3.org/2001/XMLSchema#string

Kazuto Nosaka

http://www.w3.org/2001/XMLSchema#string

Keigo Saito

http://www.w3.org/2001/XMLSchema#string

Kenichi Kohashi

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted immunotherapy for pediatric solid tumors

Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge.

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Glypicans in growth control and cancer

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.

Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.

A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors

Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors.

Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma.

P304

e1377872

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2017.1377872

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29296538

http://www.w3.org/2001/XMLSchema#string

P932

5739579

http://www.w3.org/2001/XMLSchema#string

Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors.

about

P2860

P2860

Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932